Embedded Files
The long read sequencing market in North America is expected to grow from US$ 570.24 million in 2021 to US$ 2,254.97 million by 2028; it is estimated to grow at a CAGR of 21.7% from 2021 to 2028.
North America Long Read Sequencing Market Overview
Over the past five years, genomic sequencing has evolved from a tool limited to research laboratories to a critical component of clinical practice. Today, its adoption in healthcare is accelerating, with genomic data from over 60 million patients expected to be generated globally within the next five years. This rapid integration into healthcare systems has been bolstered by significant government investments—exceeding US$4 billion across at least 14 countries. These national genomic medicine initiatives aim to address real-world implementation challenges, collect evidence for wider adoption, and ultimately drive transformative changes in patient care. As a result, they are significantly contributing to the growth of the North America Long Read Sequencing Market.
North America Long Read Sequencing Market Dynamics in North America
North America leads the global long read sequencing market, with the United States holding the dominant share, followed by Canada. The market's expansion is driven by the rising demand for gene synthesis technologies among biopharmaceutical and biotechnology firms, the presence of major industry players, and extensive R&D activities led by academic and research institutions.
Government and private sector efforts to advance precision medicine, coupled with substantial funding for genomic research, are further propelling market growth. Additionally, the COVID-19 pandemic has acted as a catalyst for genomics research and innovation, underscoring the importance of sequencing in managing public health crises.
Impact of COVID-19 on the U.S. Market
The United States was significantly impacted by the COVID-19 pandemic, facing high infection rates and a need for advanced diagnostic and surveillance tools. This urgency accelerated collaborations among scientists, healthcare providers, and research institutions to leverage genomic sequencing for understanding and controlling the spread of the virus.
While the U.S. initially lagged in genome sequencing—ranking 43rd globally and sequencing only 3% of samples according to the GISAID Initiative—efforts have since intensified. For example, Genome Canada launched the Canadian COVID Genomics Network (CanCOGeN) in April 2020 with US$40 million in funding. This initiative unites national and regional public health labs, genome centers, universities, hospitals, and the private sector to scale up COVID-19 genomic research both domestically and internationally.
Similarly, Pacific Biosciences of California, Inc. partnered with Labcorp to develop a high-throughput assay using the Sequel II system to sequence thousands of SARS-CoV-2 genomes. Such developments highlight the strategic role of long read sequencing in responding to emerging health threats and are expected to significantly boost future demand in the North America Long Read Sequencing Market.
North America Long Read Sequencing Market Segmentation
North America Long Read Sequencing Market -By Technology
Single-Molecule Real-Time Sequencing (SMRT)
Nanopore Sequencing
Loop Genomics Long-Read Sequencing
North America Long Read Sequencing Market -By Product
Instruments
Consumables
Services
North America Long Read Sequencing Market -By Application
Identification and fine mapping of structural variation
Tandem Repeat Sequencing
Pseudogene discrimination
Resolving allele phasing
Reproductive genomics
Cancer
Viral and Microbial Sequencing
Others
North America Long Read Sequencing Market -By Workflow
Pre-sequencing
Sequencing
Data Analysis
North America Long Read Sequencing Market -By End User
Academic Research Institutes
Hospitals and Clinics
Pharma and Biotechnology Companies
North America Long Read Sequencing Market -By Country
US
Canada
Mexico
North America Long Read Sequencing Market -Company Profiles
Bionano Genomics
F. HOFFMANN-LA ROCHE LTD.
Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Quantapore, Inc.
Other Reports:
North America Artificial Intelligence (AI) in Healthcare Market: https://write.as/businessmarketinsights/north-america-artificial-intelligence-ai-in-healthcare-market-emerging
North America Lactic Acid Market: https://medium.com/@ganeshsurya731/north-america-lactic-acid-market-segments-landscape-demand-and-trends-2027-b6d692ba5644
North America Disposable Gloves Market: https://business-news-insights.blogspot.com/2025/05/north-america-disposable-gloves-market.html
North America Medical Plastic Market: https://sites.google.com/view/medical-plastic-na/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Page updated
Google Sites
Report abuse